380 related articles for article (PubMed ID: 19675329)
21. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18.
Fisher ER; Wang J; Bryant J; Fisher B; Mamounas E; Wolmark N
Cancer; 2002 Aug; 95(4):681-95. PubMed ID: 12209710
[TBL] [Abstract][Full Text] [Related]
22. The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer.
Ozmen V; Ozcinar B; Bozdogan A; Eralp Y; Yavuz E; Dincer M
Eur J Surg Oncol; 2015 Oct; 41(10):1368-72. PubMed ID: 26210653
[TBL] [Abstract][Full Text] [Related]
23. Sentinel node micrometastases in breast cancer: clinical outcome.
Kihara SM; Giblett NA; McNeil C; Crea P
Asia Pac J Clin Oncol; 2010 Dec; 6(4):330-41. PubMed ID: 21114783
[TBL] [Abstract][Full Text] [Related]
24. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
[TBL] [Abstract][Full Text] [Related]
25. Lymph node micrometastases and outcome of endometrial cancer.
Ignatov A; Lebius C; Ignatov T; Ivros S; Knueppel R; Papathemelis T; Ortmann O; Eggemann H
Gynecol Oncol; 2019 Sep; 154(3):475-479. PubMed ID: 31345606
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of axillary recurrences after negative sentinel lymph node biopsy: effect on prognosis and survival.
Bulte JP; van Wely BJ; Kasper S; Kuijt G; van den Wildenberg FJ; Strobbe LJ; de Wilt JH
Breast Cancer Res Treat; 2013 Jul; 140(1):143-9. PubMed ID: 23793602
[TBL] [Abstract][Full Text] [Related]
27. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
[TBL] [Abstract][Full Text] [Related]
28. Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?
Daveau C; Stevens D; Brain E; Berges O; Villette S; Moisson P; Gardner M; De la Lande B; Lasry S; Labib A; Le Scodan R
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):337-42. PubMed ID: 20171795
[TBL] [Abstract][Full Text] [Related]
29. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
[TBL] [Abstract][Full Text] [Related]
30. Influence of isolated tumor cells in sentinel nodes on outcome in small, node-negative (pT1N0M0) breast cancer.
Leidenius MH; Vironen JH; Heikkilä PS; Joensuu H
Ann Surg Oncol; 2010 Jan; 17(1):254-62. PubMed ID: 19816743
[TBL] [Abstract][Full Text] [Related]
31. Predictive factors of isolated tumor cells and micrometastases in axillary lymph nodes in breast cancer.
Madsen EV; Elias SG; van Dalen T; van Oort PM; van Gorp J; Gobardhan PD; Bongers V
Breast; 2013 Oct; 22(5):748-52. PubMed ID: 23313060
[TBL] [Abstract][Full Text] [Related]
32. Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection.
Setton J; Cody H; Tan L; Morrow M; Hudis C; Catalano J; McCormick B; Powell S; Ho A
Cancer; 2012 Apr; 118(8):1994-2003. PubMed ID: 21882186
[TBL] [Abstract][Full Text] [Related]
33. The Sentinel Node with Isolated Breast Tumor Cells or Micrometastases. Benefits and Risks of Axillary Dissection.
Madekivi V; Boström P; Aaltonen R; Vahlberg T; Salminen E
Anticancer Res; 2017 Jul; 37(7):3757-3762. PubMed ID: 28668871
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.
Andersson Y; Frisell J; Sylvan M; de Boniface J; Bergkvist L
J Clin Oncol; 2010 Jun; 28(17):2868-73. PubMed ID: 20458033
[TBL] [Abstract][Full Text] [Related]
35. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
36. Significance and management of micrometastases in patients with breast cancer.
Mittendorf EA; Hunt KK
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1451-61. PubMed ID: 17944569
[TBL] [Abstract][Full Text] [Related]
37. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
[TBL] [Abstract][Full Text] [Related]
38. Cross-validation of three predictive tools for non-sentinel node metastases in breast cancer patients with micrometastases or isolated tumor cells in the sentinel node.
Tvedskov TF; Meretoja TJ; Jensen MB; Leidenius M; Kroman N
Eur J Surg Oncol; 2014 Apr; 40(4):435-41. PubMed ID: 24534362
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic role of axillary lymph node dissection in patients with stage IV breast cancer: a population-based analysis.
Wu SG; Li FY; Chen Y; Sun JY; Lin HX; Lin Q; He ZY
J Cancer Res Clin Oncol; 2017 Mar; 143(3):467-474. PubMed ID: 27812853
[TBL] [Abstract][Full Text] [Related]
40. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
Bulte CS; van der Heiden-van der Loo M; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]